BioAtla (BCAB)
(Delayed Data from NSDQ)
$1.73 USD
-0.03 (-1.70%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $1.81 +0.08 (4.62%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.34 | 0.00% |
Earnings Summary
For their last quarter, BioAtla (BCAB) reported earnings of -$0.44 per share, beating the Zacks Consensus Estimate of $-0.45 per share. This reflects a positive earnings surprise of 2.22%. Look out for BCAB's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.34 per share, reflecting a year-over-year increase of 51.43%.
Earnings History
Price & Consensus
Zacks News for BCAB
Can BioAtla, Inc. (BCAB) Climb 260% to Reach the Level Wall Street Analysts Expect?
BCAB: What are Zacks experts saying now?
Zacks Private Portfolio Services